companydata.dkcompanydata.dk

KEMIFARMA Consulting ApS: Financial statements 2025

CVR: 34709955

Source: annual report 2025, Danish Business Authority

01/01/2025 – 31/12/2025

KEMIFARMA Consulting ApS (CVR 34709955) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -57,469 and a net result of DKK 541,385 compared with DKK -378,700 the year before. Equity in the 2025 report amounted to DKK 3,414,022. The solvency ratio was 99.4%. The company had 1 employee in the financial year.

Gross Profit
DKK -57,469
Profit/Loss
DKK 541,385
Equity
DKK 3,414,022
Total Assets
DKK 3,433,574
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025--57K541K3.4M1
2024--97K-379K3.1M1
2023-1.4M663K3.8M1
2022-1.1M189K3.3M1
2021--122K410K3.1M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is KEMIFARMA Consulting ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

KEMIFARMA Consulting ApS: The 2024 annual report is outApr 22, 2025

KEMIFARMA Consulting ApS has published its annual report for 2024. Gross profit came to DKK -96,547, and the net result was DKK -378,700.

About KEMIFARMA Consulting ApS

KEMIFARMA Consulting ApS is a Danish company of the type Anpartsselskab based in Kgs. Lyngby, founded in 2012. The company is registered under the industry Anden teknisk rådgivning. The company was previously named KEMIFARMA HOLDING ApS. The management consists of Christian Hede-Andersen. The company is owned by Christian Hede-Andersen. The company has 1 employee (2023). In 2025, the company reported a gross profit of DKK -57,469 and a net result of DKK 541,385 compared with DKK -378,700 the year before. Equity in the 2025 report amounted to DKK 3,414,022.

Source: annual report 2025, Danish Business Authority